SKI Market

Indian Indices

Sensex

81,537.70 -769.67
( -0.94%)

Global Indices

Nasdaq

49,128.98 -276.04
(-0.56%)

Dow Jones

6,938.97 4.62
(0.07%)

Hang Seng

52,980.85 -866.02
(-1.61%)

Nikkei 225

10,138.52 -11.53
(-0.11%)

Forex

USD-INR

91.58 0.09
(0.10%)

EUR-INR

107.27 0.14
(0.13%)

GBP-INR

123.20 0.33
(0.27%)

JPY-INR

0.58 0.00
(-0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

91669

INE0PLZ01012

37.7171887

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNREST

7.08

14.16

EPS(TTM)

Face Value()

Div & Yield %

4.66

Back

Accelya Solutions India consolidated net profit declines 8.78% in the September 2025 quarter

Nov 06,2025

Net profit of Accelya Solutions India declined 8.78% to Rs 29.61 crore in the quarter ended September 2025 as against Rs 32.46 crore during the previous quarter ended September 2024. Sales rose 7.21% to Rs 136.20 crore in the quarter ended September 2025 as against Rs 127.04 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	136.20	127.04	7
OPM %	35.56	38.22	-
PBDT	49.20	51.11	-4
PBT	39.80	43.57	-9
NP	29.61	32.46	-9

81,537.70 -769.67 ( -0.94%)

49,128.98 -276.04 (-0.56%)

6,938.97 4.62 (0.07%)

52,980.85 -866.02 (-1.61%)

10,138.52 -11.53 (-0.11%)

91.58 0.09 (0.10%)

107.27 0.14 (0.13%)

123.20 0.33 (0.27%)

0.58 0.00 (-0.17%)